Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HIST1H3B | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | VGF | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | PFDN4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | AC026348.1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
mRNA | LIMK2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
mRNA | ZNF821 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
mRNA | C14orf79 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | RRAGC | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
mRNA | NANOGP8 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | LRP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |